MSB 2.17% $1.13 mesoblast limited

Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-6

  1. 2,749 Posts.
    lightbulb Created with Sketch. 1844
    Hopefully the AGM will clarify the stumbling and bumbling by the analysts on the call.

    Most positive take
    Clock starts from this new data being submitted- presume the rest of the BLA is going at the same time
    Heart partnerships WILL happen after the FDA meeting- no date set
    Back- commence USA Q2, Europe Q3

    Negative- Financials - drop in Temcell revenue.


    Reg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.